Timothy Ken and John Lem headshots

Psychedelics and the future of treating substance abuse with John Lem and Timothy Ko

Céline Williams |

Entheon Biomedical CEO Timothy Ko and John Lem, the founder of Lobo Genetics are singular in their mission to research genetic driven approaches to developing personalized tools for use in psychedelic-assisted therapeutic treatments for substance use disorders.

With firsthand knowledge of the shortcomings of the current treatment system, Ko, and Lem, the developer behind a direct-to-consumer platform being used in HaluGen’s Psychedelic Genetics test kit, the two are working together to find the right solutions for patients faster and improve outcomes.


Entrepreneurs are the backbone of Canada’s economy. To support Canada’s businesses, subscribe to our YouTube channel and follow us on FacebookInstagramLinkedIn and Twitter.

Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter

Leave a Reply

Your email address will not be published.

Related Podcasts

How an innovative tampon brand leveraged TikTok

Nadia Ladak (she/her) is passionate about the startup ecosystem and inspiring the next generation of entrepreneurial leaders. She is...

Read More

We had no idea eating salad could be so dangerous

In October 2018, their two-year-old son was infected with E. coli during the romaine lettuce outbreak. It was one...

Read More

Cannabis 101 With Industry Expert, David Marcus

David Marcus is an industry expert in all things cannabis, with over 25 years of experience and successfully lobbying...

Read More

Join Our Newsletter

Subscribe to receive info on our latest news and episodes

Subscribe